Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy

Tinnitus Clinical Trial

Official title:

Efficacy of Internet and Smartphone Application-delivered TRT

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01663467
• Other study ID #: SNUH_YHK_TRT
• Status: Withdrawn
• Phase: N/A
• First received: August 8, 2012
• Last updated: October 23, 2016
• Start date: September 2014
• Est. completion date: September 2016

Study information

• Verified date: October 2016
• Source: Seoul National University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Korea: Food and Drug Administration
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to prove the efficacy of the internet and smartphone application-delivered tinnitus retraining therapy (TRT).

Description:

to investigate the effect of TRT with minimized counseling

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: September 2016
• Est. primary completion date: September 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 65 Years

Eligibility

Inclusion Criteria:

• chronic subjective tinnitus

Exclusion Criteria:

• THI < 18

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Tinnitus

Intervention

Drug:
• Ginkgo biloba
Ginexin-F 80mg tablet will be given twice a day for 6 months.

Behavioral:
• modified TRT
modified TRT (tinnitus retraining therapy) using smartphone and web based materials will be added with Ginkgo biloba. Ginexin-F 80mg tablet will be given twice a day for 6 months.

Locations

Country	Name	City	State
Korea, Republic of	Seoul National University Hospital	Seoul

Sponsors (2)

Lead Sponsor	Collaborator
Seoul National University Hospital	Soonchunhyang University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Tinnitus Handicap Inventory (THI)	THI will be evaluated 6 months after TRT using smatrphone and web	6 months	No